| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |